- Home
- NNAVW vs WGSWW Comparison
NNAVW vs WGSWW Comparison
Compare NNAVW & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNAVW
- WGSWW
- Stock Information
- Founded
- NNAVW 2007
- WGSWW 2017
- Country
- NNAVW United States
- WGSWW United States
- Employees
- NNAVW 96
- WGSWW 1000
- Industry
- NNAVW Industrial Machinery/Components
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- NNAVW Industrials
- WGSWW Technology
- Exchange
- NNAVW Nasdaq
- WGSWW Nasdaq
- Market Cap
- NNAVW N/A
- WGSWW N/A
- IPO Year
- NNAVW N/A
- WGSWW N/A
- Fundamental
- Price
- NNAVW $5.30
- WGSWW $0.05
- Analyst Decision
- NNAVW
- WGSWW
- Analyst Count
- NNAVW 0
- WGSWW 0
- Target Price
- NNAVW N/A
- WGSWW N/A
- AVG Volume (30 Days)
- NNAVW 53.1K
- WGSWW 36.6K
- Earning Date
- NNAVW 03-12-2025
- WGSWW 02-18-2025
- Dividend Yield
- NNAVW N/A
- WGSWW N/A
- EPS Growth
- NNAVW N/A
- WGSWW N/A
- EPS
- NNAVW N/A
- WGSWW N/A
- Revenue
- NNAVW $4,963,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- NNAVW N/A
- WGSWW N/A
- Revenue Next Year
- NNAVW N/A
- WGSWW N/A
- P/E Ratio
- NNAVW N/A
- WGSWW N/A
- Revenue Growth
- NNAVW 43.44
- WGSWW 50.79
- 52 Week Low
- NNAVW $4.47
- WGSWW $0.17
- 52 Week High
- NNAVW $4.70
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- NNAVW N/A
- WGSWW N/A
- Support Level
- NNAVW N/A
- WGSWW N/A
- Resistance Level
- NNAVW N/A
- WGSWW N/A
- Average True Range (ATR)
- NNAVW 0.00
- WGSWW 0.00
- MACD
- NNAVW 0.00
- WGSWW 0.00
- Stochastic Oscillator
- NNAVW 0.00
- WGSWW 0.00
About NNAVW NextNav Inc. Warrant
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.